| Tumours | All | Women | Men | RR | (2.5%, 97.5%) | RR | (2.5%, 97.5%) | RR | (2.5%, 97.5%) |
| Stomach | 1.02 | (1.00, 1.04) | 1.01 | (0.98, 1.04) | 1.04 | (1.01, 1.07) | Liver | 1.05 | (1.00, 1.10) | 1.06 | (0.99, 1.14) | 1.05 | (1.00, 1.11) | Lung | 1.03 | (1.00, 1.05) | 0.98 | (0.94, 1.02) | 1.03 | (1.01, 1.06) | Pleura* | 1.18 | (1.09, 1.31) | 1.16 | (1.06, 1.39) | 1.2 | (1.09, 1.33) | Breast | | | 1.04 | (1.00, 1.07) | | | Bladder | 1.04 | (1.00, 1.07) | 1.01 | (0.96, 1.06) | 1.04 | (1.00,1.07) | Ill-defined tumours | 1.02 | (0.99, 1.04) | 0.99 | (0.96, 1.02) | 1.04 | (1.01,1.07) | Non-Hodgking’s lymphomas | 1.05 | (1.01, 1.08) | 1.03 | (0.99, 1.08) | 1.06 | (1.01, 1.10) | Leukemias | 1.03 | (1.00, 1.06) | 1.02 | (1.00, 1.06) | 1.04 | (1.01, 1.08) |
|
|